IPO registrations (S-1, F-1) · Registrants
Schrodinger, Inc.
- SEC CIK
- 1490978 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2020-01-10, last 2020-08-10; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2020-02-06; declared effective 2020-02-05
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1540 BROADWAY, 24TH FLOOR, New York, NY 10036
- EIN
- 95-4284541
- Ticker
- SDGR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Schrodinger, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2020-01-27)
- Final price
- $17.00 per share, above the range (424B4 filed 2020-02-06, an initial public offering)
- Shares sold
- 11,882,352
- Gross proceeds
- $201,999,984 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SDGR
- Lead underwriters
- Morgan Stanley (4,455,882 shares); BofA Securities (3,564,706 shares); Jefferies (2,732,941 shares); BMO Capital Markets (1,128,823 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SCHRODINGER, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Schrodinger, Inc. Fuzzy (name and state)
- Business registration: Schrodinger, Inc. Fuzzy (name and state)
- Business registration: SCHRODINGER, INC. Fuzzy (name and state)
- Business registration: SCHRODINGER, INC. Fuzzy (name and state)
- Business registration: SCHRODINGER, INC. Fuzzy (name and state)
- Business registration: SCHRODINGER, INC. Fuzzy (name and state)
- Business registration: Schrodinger, L.L.C. Fuzzy (name and state)
- Business registration: SCHRODINGER, L.L.C. Fuzzy (name and state)
- Form 5500 plan sponsor: SCHRODINGER, INC. EXACT (EIN (EXACT))
- Federal award recipient: SCHRODINGER, INC. Fuzzy (name and state)
- Federal award recipient: SCHRODINGER LLC Fuzzy (name and state)
- Form D issuer: Schrodinger, Inc. EXACT (CIK (EXACT))
- SEC filer: Schrodinger, Inc. EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-01-10 | S-1 | S-1 (registration) | Schrodinger, Inc. | 0001193125-20-005504 ↗ |
| 2020-01-27 | S-1/A | S-1/A (amendment) | Schrodinger, Inc. | 0001193125-20-014624 ↗ |
| 2020-02-05 | S-1MEF | S-1MEF (added securities) | Schrodinger, Inc. | 0001193125-20-025572 ↗ |
| 2020-02-05 | EFFECT | EFFECT (declared effective) | Schrodinger, Inc. | 9999999995-20-000259 ↗ |
| 2020-02-06 | 424B4 | 424B4 (final prospectus) | Schrodinger, Inc. | 0001193125-20-026787 ↗ |
| 2020-08-10 | S-1 | S-1 (registration) | Schrodinger, Inc. | 0001193125-20-214928 ↗ |
| 2020-08-12 | S-1MEF | S-1MEF (added securities) | Schrodinger, Inc. | 0001193125-20-217989 ↗ |
| 2020-08-12 | EFFECT | EFFECT (declared effective) | Schrodinger, Inc. | 9999999995-20-002125 ↗ |
| 2020-08-13 | 424B4 | 424B4 (final prospectus) | Schrodinger, Inc. | 0001193125-20-219152 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-01-27 | S-1/A | registration statement | $14.00–$16.00 | 10,000,000 | - | Nasdaq SDGR | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2020-02-06 | 424B4 | final prospectus | $17.00 | 11,882,352 | $201,999,984 | Nasdaq SDGR | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Abel Robert Lorne | Officer | EVP, Science; See Remarks | 20 | 2020–2026 | |
| Akinsanya Karen | Officer | President of R&D, Therapeutics; See Remarks | 18 | 2020–2026 | |
| BILL & MELINDA GATES FOUNDATION TRUST | TenPercentOwner | 4 | 2020 | ||
| Brauner Shane | Officer | EVP & CIO; See Remarks | 7 | 2020–2021 | |
| Daniel Jennifer | Officer | EVP & Chief HR Officer; See Remarks; SVP & Chief HR Officer | 14 | 2020–2021 | |
| D'Cruz Cony | Officer | EVP & Chief Business Officer; See Remarks | 16 | 2020–2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | TenPercentOwnerOther | 2 | 2020 | ||
| Deerfield Mgmt IV, L.P. | TenPercentOwnerOther | 2 | 2020 | ||
| Deerfield Private Design Fund IV, L.P. | TenPercentOwnerOther | 2 | 2020 | ||
| Farid Ramy | Director,Officer; Director,Officer,TenPercentOwner | President & CEO; See Remarks | 13 | 2020–2026 | |
| Flynn James E | TenPercentOwnerOther | 2 | 2020 | person page Fuzzy | |
| Friesner Richard | Director; Director,TenPercentOwner | 14 | 2020–2026 | ||
| Herman Jenny | Officer | CAO; SVP & Controller; Vice President, Controller | 19 | 2020–2026 | |
| Kapeller-Libermann Rosana | Director | 9 | 2020–2026 | ||
| Lebowitz Joel | Officer | EVP & CFO; See Remarks | 16 | 2020–2021 | |
| Lorton Kenneth Patrick | Officer | EVP & Chief Technology Officer; EVP, CTO & COO, Software; See Remarks | 23 | 2020–2026 | |
| Lynton Michael | Director | 11 | 2020–2026 | ||
| RF 2018 GRAT | TenPercentOwner | 1 | 2020 | ||
| Schrodinger Equity Holdings, LLC | TenPercentOwner | 38 | 2020–2021 | ||
| Sender Gary | Director | 9 | 2020–2026 | ||
| SHAW DAVID E | TenPercentOwner | 41 | 2020–2021 | ||
| Thornberry Nancy | Director | 10 | 2020–2026 | ||
| Tran Yvonne | Officer | EVP & Chief Legal Officer; EVP, CLO & CPO; See Remarks | 20 | 2020–2026 | |
| Weiser Jorg | Officer | EVP & Managing Director; See Remarks | 4 | 2020–2021 | |
| WRIGHT TIMOTHY MICHAEL | Director | 2 | 2020 | ||
| Deerfield Mgmt L.P. | TenPercentOwnerOther | 1 | 2020 | ||
| DEERFIELD PARTNERS, L.P. | TenPercentOwnerOther | 1 | 2020 | ||
| Chodakewitz Jeffrey | Director | 8 | 2020–2026 | ||
| GINSBERG GARY L | Director | 8 | 2020–2026 | ||
| Ardai Charles | TenPercentOwner | 2 | 2021 | ||
| OBEROI ARUN | Director | 6 | 2022–2026 | ||
| Porges Geoffrey Craig | Officer | EVP & CFO | 5 | 2022–2025 | |
| Dugan Margaret | Officer | Chief Medical Officer | 6 | 2023–2025 | |
| van Kralingen Bridget A | Director | 4 | 2025–2026 | ||
| Jain Rachit | Officer | EVP & CFO | 6 | 2025–2026 | |
| Aklian Mannix Vartan | Officer | See Remarks | 3 | 2025–2026 | |
| Abrams Therese Marie | Officer | VP, Corporate Controller | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-11-14 | Schrodinger, Inc. | Biotechnology | $115,000,000 | $107,824,987 | 13 | 2 |
| 2015-06-19 | Schrodinger, Inc. | Biotechnology | $22,000,000 | $22,000,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Schrodinger, Inc. | NY | State business registries | name and state |
| Business registration | Schrodinger, Inc. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, INC. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, INC. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, INC. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, INC. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, INC. | NY | State business registries | name and state |
| Business registration | Schrodinger, L.L.C. | NY | State business registries | name and state |
| Business registration | SCHRODINGER, L.L.C. | NY | State business registries | name and state |
| Plan sponsor | SCHRODINGER, INC. | OR | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | SCHRODINGER, INC. | NY | Federal spending (USAspending) | name and state |
| Federal award recipient | SCHRODINGER LLC | NY | Federal spending (USAspending) | name and state |
| Form D issuer | Schrodinger, Inc. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | Schrodinger, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | SCHRODINGER, INC. | EIN (EXACT) | ||
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NY first:
- SYBLEU Inc NY
- TG THERAPEUTICS, INC. NY
- SIGA TECHNOLOGIES INC NY
- SEELOS THERAPEUTICS, INC. NY
- Protagenic Therapeutics, Inc.\new NY
- XTL BIOPHARMACEUTICALS LTD NY
- PENWEST PHARMACEUTICALS CO NY
- CHEMBIO DIAGNOSTICS, INC. NY
- EYETECH PHARMACEUTICALS INC NY
- INNOVATIVE DRUG DELIVERY SYSTEMS INC NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health